Streetbeat News

Products Services

TNXP

Tonix Pharmaceuticals announced key findings from EVERSANA's market opportunity analysis for Tonmya, a potential new non-opioid treatment for fibromyalgia. The analysis revealed high interest from primary physicians and dissatisfaction with current FDA-approved drugs. Tonix plans to submit a New Drug Application to the FDA in the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:14 pm

SLNH

Soluna Holdings, Inc. (NASDAQ: SLNH) has secured $30 million in financing from Spring Lane Capital to expand its Project Dorothy data center. The new construction, set to begin in Q2 2024, will increase Soluna's Bitcoin mining capacity by 48 MW.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:13 pm

GH

Guardant Health has received EU IVDR certification for its Guardant360 CDx blood test, which is a significant milestone for the company.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:11 pm

MORF

Morphic Therapeutic (NASDAQ:MORF) presented new preclinical data at Digestive Disease Week 2024, demonstrating the real-time effects of their small molecule α4β7 inhibitor on gut-trafficking cells using Spinning Disk Intravital Microscopy. The findings show that the inhibitor rapidly increases the rolling velocity and flux of B cells in gut-associated lymphoid tissues, with effects comparable to monoclonal antibody activity.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:11 pm

RIVN

Rivian Automotive has partnered with Geotab to deliver an integrated data solution for Rivian's commercial vehicles in North America. The solution will use embedded telematics to integrate vehicle data into the MyGeotab platform, providing fleet managers with a unified dashboard to optimize fleet performance.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:10 pm

ASML

CRWD

GOOG

META

MU

NVDA

QCOM

TER

TSM

WTAI

Jeremy Schwartz, CIO at WisdomTree, emphasizes the transformative potential of AI across industries and advocates for diversified AI investments beyond Nvidia. WisdomTree's AI-focused ETF, WTAI, offers broad exposure to the AI sector, investing in 80 stocks including ARM, Meta, Nvidia, Alphabet, Qualcomm, Micron, ASML, TSM, CrowdStrike, and Teradyne. Schwartz highlights the importance of a holistic approach to AI investment to capture future developments.

Portfolio Pulse from Surbhi Jain

May 21, 2024 | 12:10 pm

BNGO

Three peer-reviewed publications demonstrate the utility of Bionano Genomics' optical genome mapping (OGM) for cell and gene therapy. The studies highlight OGM's sensitivity in detecting structural variants, making it valuable for assessing genome integrity in therapeutic cell lines.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:09 pm

NKLA

AiLO has placed an order for 100 Nikola FCEVs from Tom's Truck Centers, marking a significant step for Nikola in expanding its market presence.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:07 pm

LLY

Eli Lilly's drug mirikizumab has shown promising results in treating Crohn's disease, with over half of the patients achieving clinical remission after one year, including those who had previously failed other biologic treatments.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:06 pm

LIPO

Lipella Pharmaceuticals has received FDA Type-C meeting guidance for its LP-10 (Liposomal Tacrolimus) clinical program and plans to advance its lead product candidate to Phase 2b. The trial will evaluate LP-10 as a treatment for hemorrhagic cystitis in approximately 36 patients in the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:05 pm